The apparent absence of the bone mineral density preservation effect seen with liraglutide in MC4R -deficient patients, unlike in common obesity, underscores the need for vigilant bone health assessment and potential adjunctive interventions in this group
Insulin resistance, common in people with excess weight, impairs glucose utilization by neurons
Most are expected to follow CVS Caremark (covering Wegovy) Some may have different PA requirements Check with HR during open enrollment for any changes Medicare/Medicaid Policy Changes Medicare Part D policy changes are expected mid-2026 that could expand GLP-1 coverage
Both medicines affect GLP-1 pathways and share a dominant side-effect profile: nausea, vomiting, diarrhoea, constipation and abdominal discomfort, especially during dose escalation
Research has found that adults with type 2 diabetes who were taking Ozempic had an increased risk of developing acute pancreatitis that required hospitalization
PTP1B regulates leptin signal transduction in vivo